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Abstract
Evidence suggests that endogenous opioid peptides are
implicated in the suckling-induced prolactin rise. We
explored the role of the opioid system and the participation
of ovarian hormones in the regulation of prolactin induced
by the suckling stimulus at the end of pregnancy in rats
with developed maternal behavior, and during lactation.
Suckling for 24 h induced a significant increase in serum
prolactin on day 19 of pregnancy, which was increased
more than three times when naloxone (2 mg/kg s.c.) or
mifepristone (2 mg/kg) was administered. The combina-
tion of naloxone and mifepristone did not increase serum
prolactin more than either compound alone. Admin-
istration of tamoxifen (500 µg/kg orally) on days 14 and 15
of pregnancy completely abolished the effect of naloxone,
indicating a role for estrogens in establishing this inhibitory
role of opioids. To examine the participation of the opioid
system during lactation, we used groups of rats on days 1,
3, 5, 12 and 19 postpartum either (i) isolated from the pups
for 4 h, or (ii) isolated from the pups for 3·5 h and reunited
with them and suckled for 30 min. Naloxone, given just
before replacing the pups, prevented the increase in serum
prolactin levels observed in the suckled group of rats but
had no effect on the basal levels of the isolated rats. To
examine whether the participation of the opioid system in
the release of prolactin is dependent on the variation of
progesterone levels, rats on day 20 of pregnancy were
implanted with two cannulae containing progesterone
(that blocked postpartum ovulation) or cholesterol, and
cesarean surgery was performed on day 21. To maintain
lactation, pups (1–3 days old) were replaced every 24 h,
and 4 days after the cesarean eight pups were placed in the
cage at 1800 h to maintain a strong suckling stimulus
during the following 24 h. Naloxone administration
significantly reduced serum prolactin levels in control
(cholesterol) rats but progesterone implants prevented the
inhibitory effect of naloxone and this effect was not
modified by treatment with estrogen.
These results indicate that the opioid system modulates
suckling-induced prolactin secretion, passing from an
inhibitory action before delivery to a stimulatory action
during lactation. This regulatory shift seems to be
dependent on the fall in progesterone concentration at the
end of pregnancy and the subsequent increase after the
postpartum ovulation and luteal phase.
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Introduction
Endogenous opioid peptides play a role in the regulation of
prolactin secretion in rats during proestrus (Ieri et al. 1980),
stress (Rossier et al. 1979) and pregnancy (Sagrillo &
Voogt 1991, Soaje & Deis 1994, 1997). Additionally, the
participation of endogenous opioid peptides in the regu-
lation of prolactin release in lactating rats has been reported
by several authors (Ferland et al. 1978, Selmanoff &
Gregerson 1986, Baumann & Rabii 1991, Arbogast &
Voogt 1998). Various studies have revealed that proges-
terone has an inhibitory control on prolactin release at the
end of pregnancy (Vermouth & Deis 1972, 1974, Jahn
et al. 1986). In a previous paper (Soaje & Deis 1994) we
showed that preventing the central inhibitory action of
progesterone on prolactin release by the antiprogesterone
mifepristone (Philibert 1985) at the end of pregnancy
facilitated the release of prolactin and this effect was
enhanced by the administration of the opioid antagonist
naloxone. Our previous results demonstrated a dual
neuromodulatory regulation of prolactin secretion by the
opioid system during pregnancy. After a stimulatory action
during the first days, there is a change to an inhibitory
control of prolactin secretion starting around day 16 (Soaje
& Deis 1994, 1997).
Suckling is one of the most powerful stimuli for
prolactin release in mammalian species. It has been shown
that suckling is associated with an inhibition of tyrosine
hydroxylase (TH) activity in the arcuate nucleus (Wang
et al. 1993, Arbogast & Voogt 1998) and a decrease
in tuberoinfundibular dopaminergic (TIDA) neuronal
activity (Selmanoff & Wise 1981, Demarest et al. 1983).
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Deis et al. (1989) demonstrated that the central anti-
progesterone actions of mifepristone in pregnant rats are
not strong enough to induce prolactin secretion alone, but
are sufficient to potentiate the effect of suckling as a
prolactin releaser.
The endogenous opioid peptides have also been
implicated in the suckling-induced prolactin secretion.
Arbogast & Voogt (1998) reported that opioidergic input
was essential for normal lactation due to its effect on the
TIDA neurons. It seems that endogenous opioid peptides
decrease neuronal TIDA activity during lactation, in part,
by suppressing TH gene expression.
For many years our laboratory has been interested in
exploring the inhibitory action of progesterone on prolac-
tin secretion at the end of pregnancy. The primary goal of
this study was to establish if there is any correlation
between the changes in progesterone concentration that
occur during pregnancy and lactation and the action of the
endogenous opioid peptides in suckling-induced prolactin




Virgin female rats, 3–4 months old (200–220 g), bred in
our laboratory and originally of the Wistar strain were
used. They were kept in a light-controlled (lights on
0600–2000 h) and temperature-controlled (222 C)
room; rat chow (Cargill, Córdoba, Argentina) and tap
water were freely available. Vaginal smears were taken
daily; virgin rats showing two or three consecutive 4 day
cycles were selected. Rats were made pregnant by being
caged individually with a fertile male on the night of
proestrus. Vaginal smears were checked for the presence of
spermatozoa on the following morning and this day was
designated day 0 of pregnancy. Rats from our colony
normally deliver on day 22 of pregnancy. This day was
considered day 0 of lactation. After delivery the litters
were adjusted to eight pups and they were handled daily
until the day of the experiment. Pregnant rats with
developed maternal behavior and lactating rats were used.
The experiments were performed in accordance with
the Guidelines on the Handling and Training of Laboratory
Animals (The Biological Council, UFAW 1992).
Development of maternal behavior in pregnant rats
To study the effect of the suckling stimulus at the end of
pregnancy, we used rats with induced maternal behavior.
The development of maternal behavior of pregnant rats
was performed as previously described (Deis et al. 1989).
Briefly, virgin female rats showing regular 4 day cycles
were introduced into special maternal cages (Gonzalez &
Deis 1986) on diestrus day 2 at 1800 h. On the following
proestrus, a male and three 1- to 3-day-old freshly
nourished young were introduced at 1800 h into the
maternal cage. The morning after mating, if spermatozoa
were found in the vaginal smears, was considered as day 0
of pregnancy. The male was removed from the cage and
the pups replaced by recently fed pups every 12 h. After
development of maternal behavior, the rats were kept with
pups for 5 days to consolidate maternal experience. After a
period of 10–12 days without pups, the rats were provided
with foster young to reinforce the development of the
maternal behavior. This procedure is quite adequate to
provide the stimulus of suckling at any time of pregnancy.
The well-developed nipples in the mammary glands on
day 18 of pregnancy facilitate the establishment of suck-
ling. All the rats used showed evidence of suckled nipples
during the experiment.
Experimental procedures
Experiment 1 This experiment was designed to deter-
mine whether naloxone administration, in association with
the suckling stimulus, applied during late pregnancy is able
to induce prolactin secretion with or without previous
treatment with mifepristone. Rats on day 19 of pregnancy
with or without induced maternal behavior were used. A
litter of eight pups (4–6 days old) was introduced into the
maternal cages at 1800 h on day 18 of pregnancy and they
remained with the pregnant rats with induced maternal
behavior for the next 24 h. The opioid antagonist naloxone
(2 mg/kg i.p.) (Sigma Chemical Co., St Louis, MO, USA)
or saline was administered at 1730 h to rats pre-treated
with mifepristone dissolved in corn oil (2 mg/kg s.c.) or
vehicle at 0800 h. The animals were decapitated 30 min
after treatment with naloxone or saline, blood samples
were allowed to clot at room temperature and serum was
separated and stored frozen (30 C) until assayed for
prolactin and progesterone.
Experiment 2 This experiment was performed to deter-
mine the role of estrogen and the opioid system in rats with
the suckling stimulus applied at the end of pregnancy.
Based on our previous results (Soaje & Deis 1997),
tamoxifen citrate (Gador S.A., Buenos Aires, Argentina)
was dissolved in 0·14 M NaCl, 0·5% (v/v) Tween 80 and
administered orally at a dose of 500 µg/kg body weight at
1200 h on days 14 and 15 of pregnancy. Eight pups were
introduced into the maternal cages at 1800 h on day 18 of
pregnancy and remained with the pregnant rats for the
next 24 h. On day 19 of pregnancy, saline or naloxone was
administered at 1730 h and blood samples were obtained
by decapitation 30 min afterwards.
Experiment 3 To evaluate the participation of the opioid
system during lactation, groups of lactating rats on days 1,
3, 5, 12 and 19 were isolated from the litter at 1400 h.
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Immediately before the replacement of the pups at 1730 h,
naloxone or saline was administered. After a suckling
period of 30 min, the mothers were decapitated and
blood samples were obtained for determination of serum
concentration of prolactin and progesterone.
Experiment 4 At the end of pregnancy there is a fall in
serum progesterone concentration with a simultaneous
increase in serum estrogen levels that is necessary to
induce an increase in serum prolactin concentration,
lactogenesis and parturition. After postparturition ovula-
tion, serum progesterone levels increase and remain
elevated during lactation. The present experiment was
designed to examine whether the participation of the
opioid system in the release of prolactin may be dependent
on the decrease of progesterone levels that occurs before
labor and the increase during lactation. Rats on day 20 of
pregnancy were implanted s.c. at 1800 h with two silastic
cannulae containing progesterone to maintain elevated
serum levels of this steroid. Twenty-four hours later, a
cesarean was performed and six pups (1–3 days old)
obtained from lactating donor mothers were introduced
into the cage to induce maternal behavior. The pups were
replaced every 24 h. Four days after cesarean surgery a
litter of eight young (4–6 days old) was introduced into the
cage at 1800 h to maintain a strong suckling stimulus
during the following 24 h. The control animals were
implanted with silastic cannulae containing cholesterol.
Naloxone (2 mg/kg) or saline was administered at 1730 h
on day 5 after parturition and blood samples were obtained
by decapitation 30 min afterwards.
Another group of hormone-implanted rats on the
same schedule was treated s.c. with 5 or 10 µg/rat
estradiol benzoate (Schering, Buenos Aires, Argentina) on
days 1 and 3 of lactation respectively.
Prolactin and progesterone determinations
Prolactin was measured by a double-antibody RIA using
materials generously provided by the National Hormone
and Pituitary Program of the US National Institute of
Diabetes, Digestive and Kidney Diseases (NIDDK)
(Bethesda, MD, USA). Prolactin was radioiodinated using
the chloramine T method (Niswender et al. 1969) and
purified by passage through Sephadex G-75 and poly-
acrylamide agarose (ACA 54; LKB, Bromma, Sweden)
columns. The assay sensitivity was 1 ng/ml serum and the
inter- and intra-assay coefficients of variation were less
than 10%. Serum progesterone was measured using an
RIA developed in our laboratory (Bussmann & Deis 1979)
with an antiserum raised in a rabbit against progesterone-
11-BSA conjugate. Assay sensitivity was less than 3 ng/ml
serum and the inter- and intra-assay coefficients of vari-
ation were less than 10%. Prolactin does not cross-react
with placental lactogen (Robertson & Friesen 1981).
Statistics
Statistical evaluations were performed using Student’s
t-test to assay significant differences between means of two
groups. One-way ANOVA followed by Tukey’s test was
used for multiple comparisons. A value of P<0·05 was
considered statistically significant (Snedecor & Cochran
1967).
Results
Experiment 1. Serum prolactin levels after suckling stimulus
applied on day 19 of pregnancy: effect of naloxone and
mifepristone plus naloxone treatment
Confirming previous results from this laboratory (Soaje &
Deis 1994, 1997), naloxone administration to control rats
did not modify serum prolactin levels while naloxone in
rats pre-treated with mifepristone induced a slight but
significant increase in serum prolactin levels (Fig. 1).
Twenty-four hours of suckling induced a significant
increase in serum prolactin, as previously described (Deis
et al. 1989) and naloxone administration potentiated this
increase more than 2-fold (Fig. 1). As previously shown
(Deis et al. 1989), mifepristone administration induced an
important increase in serum prolactin levels in rats with
24 h of suckling. However, this increase was not elevated
further by naloxone treatment. There were no significant
differences in serum progesterone concentrations in
suckled rats after administration of mifepristone or
naloxone (not shown).
Figure 1 Effect of saline or naloxone on serum prolactin
concentration on day 19 of pregnancy in non-suckled and suckled
rats pre-treated with oil vehicle (v) or mifepristone. Results are
meansS.E.M. of groups of 7–12 animals. v P<0·05 compared
with non-suckled rats treated with vehicle plus saline. **P<0·01
compared with suckled rats treated with vehicle plus saline.
*P<0·05 compared with non-suckled rats treated with
mifepristone plus saline. vv P<0·01 compared with suckled rats
treated with mifepristone plus saline.
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Experiment 2. Effect of tamoxifen administration on serum
prolactin levels on day 19 of pregnancy in suckled
naloxone-treated rats
The administration of tamoxifen on days 14 and 15
of pregnancy reduced to 13·966·84 ng/ml (...)
(P<0·05) the elevated serum prolactin levels observed in
rats on day 19 of pregnancy after 24 h of suckling
(48·5412·33 ng/ml). This treatment also abolished the
important prolactin increase observed after naloxone treat-
ment in rats with 24 h of suckling (146·02·90 ng/ml vs
11·574·13 ng/ml; P<0·01).
Experiment 3. Serum prolactin and progesterone concentrations
in lactating rats: effect of naloxone treatment
In pup-deprived dams, serum prolactin concentrations
were low on all the days of lactation studied and no effect
of naloxone was observed (Fig. 2a). When the pups were
isolated for 3·5 h from the mother and replaced for 30 min,
a significant rise in serum prolactin concentrations was
observed on the selected days of lactation. Simultaneous
administration of naloxone with the suckling stimulus
prevented the increase in serum prolactin previously
observed on all the experimental days (Fig. 2b).
The pattern of circulating progesterone measured
at 1800 h on different days of lactation in mothers
with continuous suckling was not modified by naloxone
treatment (Fig. 2c).
Experiment 4. Effect of progesterone, estrogen and naloxone
treatment on serum prolactin levels in rats on day 5 of
lactation
In this experimental model, the fall of progesterone levels
occurring at the end of pregnancy and the rise that occurs
after postpartum ovulation was prevented by the s.c.
implantation of silastic cannulae containing progesterone.
The progesterone implants on day 20 of pregnancy were
able to prevent postpartum ovulation since macroscopic
examination of the ovaries showed absence of new corpora
lutea, indicating an absence of estrogen effect. The ovaries
of the cholesterol-implanted rats showed populations of
new corpora lutea, and circulating progesterone levels on
day 5 postcesarean were not different from those of normal
lactating rats on the same day of lactation (not shown).
Circulating prolactin in the dams bearing cannulae con-
taining progesterone or cholesterol was similar to that of
untreated rats on day 5 of lactation. Naloxone admin-
istration significantly reduced serum prolactin concen-
trations on day 5 of lactation (Fig. 3) in the dams implanted
with cholesterol, but the reduction in serum prolactin
levels induced by naloxone was prevented by the proges-
terone implants. Moreover, pre-treatment with estradiol of
progesterone-implanted rats had no effect on serum pro-
lactin levels in saline- or naloxone-treated rats on day 5 of
lactation.
Figure 2 (a) Effect of saline or naloxone on serum prolactin
concentration on days 1, 3, 5, 12 and 19 of lactation in
pup-deprived dams. Results are meansS.E.M. of groups of
7–11 animals. There are no significant differences between saline-
and naloxone-treated rats. (b) Effect of saline or naloxone on
serum prolactin concentration on days 1, 3, 5, 12 and 19 of
lactation in pup-suckled dams. Results are meansS.E.M. of groups
of 7–12 animals. *P<0·05, **P<0·01 compared with the respective
control. (c) Effect of saline or naloxone on serum progesterone
concentration on days 1, 3, 5, 12, 19 of lactation. Results are
meansS.E.M. of groups of 7–12 animals. *P<0·05, **P<0·01
compared with day 1 and 19.
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Discussion
Previous studies have demonstrated that progesterone acts
centrally to prevent the release of prolactin at the end of
pregnancy. Also, an inverse correlation between the
secretion of progesterone and prolactin levels has been
established (Vermouth & Deis 1972, 1974, Jahn et al.
1986, Deis et al. 1989). Our present results show that the
administration of naloxone significantly increased prolactin
secretion in pregnant-suckled rats in spite of the elevated
serum progesterone concentration. These results are in
agreement with our earlier reports (Soaje & Deis 1994,
1997) where the administration of mifepristone was not
able to induce prolactin release but facilitated the inhibi-
tory opioid regulation of prolactin release at the end of
pregnancy. We have also demonstrated (Soaje et al. 1998)
that administration of the antiprogesterone to rats on
day 19 of pregnancy diminishes the turnover of dopamine
in the medial basal hypothalamus. However, naloxone
treatment after mifepristone administration did not modify
the turnover of dopamine compared with mifepristone
treatment alone. Given that an important increase in
prolactin secretion was observed after naloxone admin-
istration to rats pre-treated with mifepristone (Fig. 1)
(Soaje & Deis 1994, 1997), we may suggest that a fall of
the dopaminergic tone facilitates an inhibitory opioid
effect exerted through a non-dopaminergic pathway. In
fact, evidence suggests that progesterone may regulate
TIDA neuronal activity. In adult rats in estrus, progester-
one treatment increased the turnover of dopamine in
the medial basal hypothalamus and preoptic area and
diminished prolactin release through the activation of the
dopaminergic system (Tomogane et al. 1990). More-
over, progesterone administration increases dopamine
concentrations in portal blood (Cramer et al. 1979).
Several reports indicate that suckling-induced prolactin
increase occurs due to a rapid and transient decrease in
TIDA activity (Selmanoff & Wise 1981, Demarest et al.
1983, De Greef et al. 1987, Wang et al. 1993, Arbogast &
Voogt 1998), which sensitizes the lactotropes to releasing
factors (Neill & Nagy 1994). Comparing these findings
with the present results, we may suggest that the suckling
stimulus induces a decrease of dopaminergic tone that in
turn facilitates naloxone action. In the present study, we
also show that mifepristone is able to potentiate the
stimulatory effect of suckling on prolactin release, confirm-
ing previous results (Deis et al. 1989). Thus, the central
antiprogesterone action of mifepristone alone is not
sufficient to induce prolactin secretion, but it is able to
potentiate the effect of other prolactin releasers such as
suckling. Interestingly in the present experiments, mife-
pristone administration induced an increase in serum
prolactin levels only in suckled rats and this increase was
not modified by naloxone treatment. In previous results
obtained in our laboratory (Jahn & Deis 1987, 1988, Soaje
& Deis 1994, 1997) we described an increase in serum
prolactin levels at the end of pregnancy after serotoninergic
or opioid antagonist administration. The increase in serum
prolactin levels was no more than 15050 ng/ml. Since
naloxone was not able to increase further the prolactin
levels after mifepristone administration it is probable that
the capacity of the hypophysis to release prolactin at the
end of pregnancy is not very high when compared with
lactating rats.
During pregnancy there is an increase in serum estrogen
concentration on day 3, after which the steroid concen-
tration remains very low until days 15–16 when it starts to
increase progressively until parturition (Yoshinaga et al.
1969, Shaik 1971). Also, it is well known that estrogens
stimulate the synthesis and the release of prolactin through
an action at the hypothalamic and hypophyseal level
(Chen & Meites 1970). Moreover, it has been shown that
the neurons of the arcuate nucleus responsible for produc-
ing opioid peptides are able to concentrate estrogen
(Morrell et al. 1985, Jirikowski et al. 1986) and that
estrogen regulates proopiomelanocortin gene expression
(Wilcox & Roberts 1985, Treiser & Wardlaw 1992, Priest
& Roberts 2000). An interesting finding from the present
study is that the administration of tamoxifen on days 14
and 15 of pregnancy abolished the high prolactin levels
observed in rats on day 19 of pregnancy with 24 h of
suckling plus saline or suckling plus naloxone. Thus, the
present and previous results (Soaje & Deis 1997) indicate
that the presence of estrogen on day 15–16 of pregnancy is
an important hormonal factor for the activation of the
opioid system as a neuromodulator of prolactin secretion at
the end of pregnancy.
Administration of naloxone to lactating rats reduced the
effect of acute suckling on serum prolactin concentrations
on all the days studied. Quite a bit of evidence supports
these results demonstrating a participation of the opioid
system on suckling-induced hormone release (Ferland
et al. 1978, Selmanoff & Gregerson 1986, Baumann &
Figure 3 Effect of saline (S) or naloxone (N) on serum prolactin
concentration in rats on day 5 of lactation after different
treatment. C=cholesterol, P=progesterone, P+E=progesterone
plus estrogen. Results are meansS.E.M. of groups of 7–12
animals. **P<0·01 compared with C+S (Student’s t-test).
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Rabii 1991). Moreover, Arbogast & Voogt (1998) recently
reported that opioidergic input is essential for normal
lactation due to its effects on the TIDA neurons. It seems
that the suckling-induced inhibition of TIDA neurons is
mediated through the endogenous opioid peptides acting
at µ- but not -opioid receptors (Callahan et al. 1996). In
the present study, we found no correlation between the
effect of naloxone and the various serum progesterone
concentrations during lactation, indicating independence
of the opioid system to changes in progesterone levels
during lactation. However, our results suggest that the
fall in serum progesterone concentrations at the end of
pregnancy followed by the increase during lactation are
necessary events to determine the opioid inhibition or
opioid stimulation of prolactin release respectively. In our
experimental model, we prevented the changes in circu-
lating progesterone at the end of pregnancy and after
postpartum ovulation with silastic cannulae that contained
progesterone. The absence of new corpora lutea indicated
the lack of postpartum ovulation and therefore the absence
of estrogen action. Interestingly, no effect of naloxone on
prolactin release was observed in these experimental
groups. Since the administration of estrogen did not
reverse the lack of effect of naloxone on prolactin release it
would seem that estrogen does not participate in the action
of the opioid on prolactin release during lactation.
Thereby, we can suggest that the spontaneous fall in
progesterone concentration at the end of pregnancy and its
subsequent increase after postpartum ovulation are neces-
sary for determining the role of the opioid system on
prolactin release in lactating rats. However, further studies
are necessary to establish this mechanism.
In conclusion, the present results support the proposal
that endogenous opioid peptides are involved in the
suckling-induced prolactin secretory response. We
demonstrate that the suckling stimulus applied at the end
of pregnancy is also subject to inhibitory modulation by
opioids in the presence of high circulating levels of
progesterone, while during lactation opioids mediate
suckling-induced prolactin release in a stimulatory fashion.
However, the shift from inhibitory to stimulatory action of
the opioid system on prolactin secretion during lactation
seems to be dependent on the characteristic changes in
circulating progesterone levels at the end of pregnancy and
during the first days of lactation.
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